Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMC 345177)

Published in Proc Natl Acad Sci U S A on May 01, 1984

Authors

P Clapham, K Nagy, R A Weiss

Articles citing this

Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Natl Acad Sci U S A (1985) 4.28

Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J Virol (1990) 2.66

Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus. J Virol (1998) 2.09

Subregions of a conserved part of the HIV gp41 transmembrane protein are differentially recognized by antibodies of infected individuals. EMBO J (1986) 2.01

Ping-pong amplification of a retroviral vector achieves high-level gene expression: human growth hormone production. J Virol (1990) 1.78

Infection of human endothelial cells by human T-cell leukemia virus type I. Proc Natl Acad Sci U S A (1984) 1.61

Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins. J Virol (1992) 1.32

Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison. J Gen Virol (2008) 1.27

Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection. EMBO J (1987) 1.27

Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I. J Virol (1985) 1.23

Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people. J Virol (1989) 1.17

Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). Int J Exp Pathol (2001) 1.06

Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46. J Virol (1997) 1.06

Isolation of a human T-lymphotropic virus type I strain from Australian aboriginals. J Virol (1993) 1.04

71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1. J Virol (1998) 1.01

Identification of new gene products coded from X regions of human T-cell leukemia viruses. Proc Natl Acad Sci U S A (1985) 0.99

Role of heterologous and homologous glycoproteins in phenotypic mixing between Sendai virus and vesicular stomatitis virus. J Virol (1989) 0.98

Serological cross-reactivity between envelope gene products of type I and type II human T-cell leukemia virus. Proc Natl Acad Sci U S A (1984) 0.93

CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses. J Virol (1990) 0.90

Human T-cell growth factor (interleukin 2) and gamma-interferon genes: expression in human T-lymphotropic virus type III- and type I-infected cells. Proc Natl Acad Sci U S A (1985) 0.90

Monoclonal antibodies and chemiluminescence immunoassay for detection of the surface protein of human T-cell lymphotropic virus. J Clin Microbiol (1992) 0.83

Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans. J Virol (2000) 0.82

Formation of vesicular stomatitis virus pseudotypes bearing surface proteins of hepatitis B virus. J Virol (2005) 0.81

Characterisation of cytoplasmic DNA complementary to non-retroviral RNA viruses in human cells. Sci Rep (2014) 0.81

Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells. J Virol (1997) 0.81

Feline immunodeficiency virus (FIV) neutralization: a review. Viruses (2011) 0.80

Analogy between lymphotropic human retroviruses and large animal retroviruses. Can Vet J (1986) 0.75

Retrovirus infections among patients treated in Britain with various clotting factors. Br Med J (Clin Res Ed) (1986) 0.75

Analogie entre les rétrovirus humains lymphotropes et les rétrovirus des grands animaux. Can Vet J (1986) 0.75

Articles cited by this

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08

Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A (1982) 12.84

Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A (1981) 11.92

Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood (1977) 10.69

Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature (1981) 9.25

A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science (1982) 5.30

Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science (1983) 4.67

Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia. Nature (1981) 4.38

Adult T-cell lymphoma-leukaemia in Blacks from the West Indies. Lancet (1982) 3.67

Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. Science (1982) 3.37

Human adult T-cell leukemia virus: molecular cloning of the provirus DNA and the unique terminal structure. Proc Natl Acad Sci U S A (1982) 3.19

Pseudotypes of vesicular stomatitis virus with the coat of murine leukaemia and of avian myeloblastosis viruses. J Gen Virol (1972) 2.82

The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group. Nature (1982) 2.75

Growth of pseudotypes of vesicular stomatitis virus with N-tropic murine leukemia virus coats in cells resistant to N-tropic viruses. J Virol (1973) 2.75

Primary structure analysis of the major internal protein p24 of human type C T-cell leukemia virus. Proc Natl Acad Sci U S A (1982) 2.57

Host restriction of Friend leukemia virus. Role of the viral outer coat. Proc Natl Acad Sci U S A (1973) 2.44

Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer (1982) 2.39

Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line. Science (1983) 2.26

Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera. Int J Cancer (1983) 2.08

Assembly of membrane glycoproteins studied by phenotypic mixing between mutants of vesicular stomatitis virus and retroviruses. Virology (1980) 1.82

Human T-cell leukaemia/lymphoma virus-associated lymphoreticular neoplasia in Jamaica. Lancet (1983) 1.69

Pseudotypes of avian sarcoma viruses with the envelope properties of vesicular stomatitis virus. Virology (1977) 1.67

Retrovirus terminology. Science (1983) 1.47

Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytia induction assay. Proc Natl Acad Sci U S A (1983) 1.43

Pseudotypes of vesicular stomatitis virus with envelope antigens provided by murine mammary tumor virus. Virology (1977) 1.21

Pseudotypes of vesicular stomatitis virus determined by exogenous and endogenous avian RNA tumor viruses. Virology (1974) 1.18

Virus envelope markers in mammalian tropism of avian RNA tumor viruses. J Virol (1975) 1.09

African green monkeys are infected with adult T-cell leukaemia virus or closely related agent. Lancet (1983) 0.87

Identification of infectious virions which are vesicular stomatitis virus pseudotypes of murine type C virus. Virology (1976) 0.83

Antibodies against three purified structural proteins of the human type-C retrovirus, HTLV, in Japanese adult T-cell leukemia patients, healthy family members, and unrelated normals. Int J Cancer (1983) 0.83

Monoclonal and polyclonal antibody studies of VSV(hrMMTV) pseudotypes. Virology (1982) 0.81

Neutralization of Mason-Pfizer virus by sera from patients treated for renal disease. J Gen Virol (1978) 0.81

A rapid neutralization test for antibodies to bovine leukemia virus, with the use of rhabdovirus pseudotypes. J Natl Cancer Inst (1979) 0.79

Detection of type C virus particles in Japanese monkeys seropositive to adult T-cell leukemia-associated antigens. Gan (1982) 0.79

Articles by these authors

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47

Ensembl 2009. Nucleic Acids Res (2008) 25.38

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell (1986) 22.26

Laser capture microdissection. Science (1996) 12.21

Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science (1990) 10.13

Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med (1995) 6.71

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature (1985) 6.65

Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science (1996) 6.57

Infection of human cells by an endogenous retrovirus of pigs. Nat Med (1997) 5.71

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS (1990) 5.48

A new classification for HIV-1. Nature (1998) 5.30

Variable and conserved neutralization antigens of human immunodeficiency virus. Nature (1987) 5.29

Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet (1984) 5.20

High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol (1995) 4.59

Genetic recombinants and heterozygotes derived from endogenous and exogenous avian RNA tumor viruses. Virology (1973) 4.56

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A (1999) 4.52

Epitopes of the CD4 antigen and HIV infection. Science (1986) 4.50

Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol (1996) 4.43

The CD4 antigen: physiological ligand and HIV receptor. Cell (1988) 4.42

HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood (2000) 4.22

Receptor interference groups of 20 retroviruses plating on human cells. Virology (1990) 4.15

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05

Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol (1984) 4.00

Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBO J (1988) 3.98

Characterization of HIV-1 neutralization escape mutants. AIDS (1989) 3.88

Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. Nature (1983) 3.86

Identification of the residues in human CD4 critical for the binding of HIV. Cell (1989) 3.71

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science (1997) 3.70

The pH independence of mammalian retrovirus infection. J Gen Virol (1990) 3.68

Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus. Virology (1991) 3.54

Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature (1989) 3.54

Virus infection of murine teratocarcinoma stem cell lines. Cell (1977) 3.54

Cyclin encoded by KS herpesvirus. Nature (1996) 3.32

Detection of avian tumor virus-specific nucleotide sequences in avian cell DNAs (reassociation kinetics-RNA tumor viruses-gas antigen-Rous sarcoma virus, chick cells). Proc Natl Acad Sci U S A (1972) 3.28

Neutralizing monoclonal antibodies to the AIDS virus. AIDS (1988) 3.06

An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature (1989) 3.01

Induction of avian tumor viruses in normal cells by physical and chemical carcinogens. Virology (1971) 3.00

Host range and interference studies of three classes of pig endogenous retrovirus. J Virol (1998) 2.94

HIV infection does not require endocytosis of its receptor, CD4. Cell (1988) 2.88

HIV infection and neoplasia. Lancet (1996) 2.83

Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J Virol (1992) 2.80

Two sets of human-tropic pig retrovirus. Nature (1997) 2.74

Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4. J Virol (1992) 2.59

KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene (1997) 2.57

Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4. AIDS (1990) 2.46

A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J Virol (1993) 2.46

Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections. J Virol (1993) 2.43

Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol (1995) 2.36

Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol (1994) 2.36

The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. AIDS (1988) 2.35

Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1988) 2.34

Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet (1987) 2.34

Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Intern Med (1996) 2.33

Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children. J Urol (1997) 2.32

No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet (1998) 2.32

Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester. Virology (1987) 2.30

DNA in medicine. Oncogenes. Lancet (1984) 2.28

Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line. Science (1983) 2.26

The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol (1997) 2.24

Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology (1999) 2.23

Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst (1998) 2.23

Single channel Ca2+ currents in Helix pomatia neurons. Pflugers Arch (1981) 2.21

Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS (1997) 2.20

Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virol (1999) 2.09

Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet (1985) 2.08

Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera. Int J Cancer (1983) 2.08

Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology (1988) 2.05

Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood (1998) 1.95

Host gene control of endogenous avian leukosis virus production. Virology (1974) 1.94

Morphological and biochemical characterization of viral particles produced by the tsO45 mutant of vesicular stomatitis virus at restrictive temperature. J Virol (1979) 1.93

Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol (1999) 1.90

Human T cell leukemia viruses use a receptor determined by human chromosome 17. Science (1988) 1.87

HIV infection of primate lymphocytes and conservation of the CD4 receptor. Nature (1988) 1.84

Assembly of membrane glycoproteins studied by phenotypic mixing between mutants of vesicular stomatitis virus and retroviruses. Virology (1980) 1.82

Evidence for heterosexual transmission and clinical manifestations of human immunodeficiency virus infection and related conditions in Lusaka, Zambia. Lancet (1986) 1.80

Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proc Natl Acad Sci U S A (1992) 1.77

Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus. Arthritis Rheum (1999) 1.76

Keratin classes: molecular markers for different types of epithelial differentiation. J Invest Dermatol (1983) 1.76

Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J Virol (1997) 1.75

Kaposi's sarcoma-associated herpesvirus. Adv Cancer Res (1998) 1.72

Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation. J Gen Virol (1987) 1.71

CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology (1997) 1.70

HIV infection: the cellular picture. Sci Am (1988) 1.68

Pseudotypes of avian sarcoma viruses with the envelope properties of vesicular stomatitis virus. Virology (1977) 1.67

Multiple groups of novel retroviral genomes in pigs and related species. J Virol (2001) 1.67

A transforming gene present in human sarcoma cell lines. Nature (1982) 1.67

Foamy retroviruses. A virus in search of a disease. Nature (1988) 1.64

Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.64

HIV-1 tropism and co-receptor use. Nature (1997) 1.60

HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages. Virology (1994) 1.56

Scanning electron microscopy of cells in culture. Exp Cell Res (1972) 1.56

Abundance of an endogenous retroviral envelope protein in placental trophoblasts suggests a biological function. Virology (1995) 1.56

Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction. Virology (1992) 1.56

Extensive tissue necrosis following high-concentration sclerotherapy for varicose veins. Dermatol Surg (2000) 1.55

The heritable nature of the factor in chicken cells which acts as a helper virus for Rous sarcoma virus. Virology (1971) 1.54

Role of CD4 endocytosis in human immunodeficiency virus infection. J Virol (1995) 1.53